Overexpression of human epidermal growth factor receptor 2

(HER2) occurs in a large percentage of breast cancers.

Monoclonal antibodies targeting HER2 are vastly used for both

diagnostic and therapeutic ...

Introduction: Development of molecular probes that bind specifically

and with high affinity to cancer biomarkers is one of the most

important objectives in the early diagnosis and therapy of cancer.

HER2, ...